Related references
Note: Only part of the references are listed.Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma
Muhammad Ramzan et al.
LIVER INTERNATIONAL (2016)
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
Heather VanSeggelen et al.
MOLECULAR THERAPY (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
Loredana Cifaldi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
Inhibitory receptors beyond T cell exhaustion
Silvia A. Fuertes Marraco et al.
FRONTIERS IN IMMUNOLOGY (2015)
Effect of NKG2D ligand expression on host immune responses
Marine Champsaur et al.
IMMUNOLOGICAL REVIEWS (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury
Silke Marhenke et al.
GUT (2014)
Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation
Nazanin Farhadi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients
Courtney A. Crane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire
Sam Sheppard et al.
BLOOD (2013)
A selective role of NKG2D in inflammatory and autoimmune diseases
Nadia Guerra et al.
CLINICAL IMMUNOLOGY (2013)
Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice
Mei Huang et al.
HEPATOLOGY (2013)
Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants
H. V. Tong et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk
Paulisally Hau Yi Lo et al.
PLOS ONE (2013)
Bystander-Activated Memory CD8 T Cells Control Early Pathogen Load in an Innate-like, NKG2D-Dependent Manner
Talyn Chu et al.
CELL REPORTS (2013)
New prospects on the NKG2D/NKG2DL system for oncology
Evelyn Ullrich et al.
ONCOIMMUNOLOGY (2013)
The speed of change: towards a discontinuity theory of immunity?
Thomas Pradeu et al.
NATURE REVIEWS IMMUNOLOGY (2013)
RAE-1ε Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition
Mary A. Markiewicz et al.
IMMUNITY (2012)
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence
Hiroteru Kamimura et al.
JOURNAL OF HEPATOLOGY (2012)
Cancer Immunotherapy Using a Bispecific NK Receptor Fusion Protein that Engages both T Cells and Tumor Cells
Tong Zhang et al.
CANCER RESEARCH (2011)
Immune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis
Mingcan Xia et al.
CIRCULATION (2011)
A dual role for the immune response in a mouse model of inflammation-associated lung cancer
Michael Dougan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells
Andrea Caballero Benitez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Intraepithelial T Cell Response to NKG2D-Ligands Links Lymphoid Stress Surveillance to Atopy
Jessica Strid et al.
SCIENCE (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Intact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1
Marine Champsaur et al.
JOURNAL OF IMMUNOLOGY (2010)
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Alan P. Venook et al.
ONCOLOGIST (2010)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Mononuclear myeloid-derived suppressor cells express RAE-1 and activate natural killer cells
Norman Nausch et al.
BLOOD (2008)
Direct and natural killer cell-mediated antitumor effects of low-dose Bortezomib in hepatocellular carcinoma
Sorin Armeanu et al.
CLINICAL CANCER RESEARCH (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
The expression and function of NKG2D molecule on intrahepatic CD8+T cells in chronic viral hepatitis
P. T. F. Kennedy et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis
Jessica Strid et al.
NATURE IMMUNOLOGY (2008)
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Noam Stern-Ginossar et al.
NATURE IMMUNOLOGY (2008)
NKG2D ligands in tumor immunity
N. Nausch et al.
ONCOGENE (2008)
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
Jeremy B. Swann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus
Silvia Vilarinho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Promiscuity and the single receptor: NKG2D
Robert A. Eagle et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis
Scott J. Roberts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
Luca Di Tommaso et al.
HEPATOLOGY (2007)
Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
K Wiemann et al.
JOURNAL OF IMMUNOLOGY (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
B Meresse et al.
IMMUNITY (2004)
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
JS Lee et al.
NATURE GENETICS (2004)
NKG2D blockade prevents autoimmune diabetes in NOD mice
K Ogasawara et al.
IMMUNITY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
The distinct contributions of murine T cell receptor (TCR)γδ+ and TCRαβ+ T cells to different stages of chemically induced skin cancer
M Girardi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rhe'umatoid arthritis
V Groh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
S Gilfillan et al.
NATURE IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Share Paper
